<DOC>
	<DOCNO>NCT03101709</DOCNO>
	<brief_summary>This clinical study observe safety feasibility chimeric antigen receptor 19 ( CART-19 ) cell relapse refractory patient CD19+ B cell lymphoma .</brief_summary>
	<brief_title>The Safety Efficacy CART-19 Cells Relapse Refractory Patients With CD19+ B-cell Lymphoma</brief_title>
	<detailed_description>This study patient B cell lymphoma . Subjects stag suitability T cell CART-19 manufacturing determine entry phase . Subjects collect T cell modify , modification genetic change , CD19:4-1BB : CD3 modify T cell , order tell T cell recognize target tumor cell potentially kill , normal cell subject 's body . The CART cell expand vitro administer subject . The purpose study assess ss safety feasibility CART-19 cell patient relapse refractory CD19+ B cell lymphoma .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<criteria>1 . 18 year 70 year , expect survival &gt; 3 month ; 2 . CD19 positive Bcell lymphoma ; 3 . KPS &gt; 80 ; 4 . Having least one measurable lesion ; 5 . Cardiac function : 12 level ; Liver : TBIL≤3ULN，AST ≤2.5ULN，ALT ≤2.5ULN ; kidney : Cr≤1.25ULN ; bone marrow : WBC ≥ 3.0×109/L , Hb ≥90 g/L , PLT ≥ 80×109/L） ; 6 . No serious allergic constitution ; 7 . No serous disease conflict clinical program ; 8 . No cancer history ; 9 . No serious mental disorder ; 10 . Informed consent sign subject lineal relation . 1 . Pregnant lactating woman ; ( female participant reproductive potential must negative serum urine pregnancy test ) ; 2 . Uncontrolled active infection , HIV infection , syphilis serology reaction positive ; 3 . Active hepatitis B hepatitis C infection ; 4 . Recent current use glucocorticoid immunosuppressor ; 5 . With severe cardiac , liver , renal insufficiency , diabetes disease ; 6 . Transaminase &gt; 2.5ULN , Bilirubin &gt; 3ULN，Creatinine &gt; 1.25ULN 7 . Participate clinical research past three month ; previously treatment gene therapy product ; 8 . Researchers think fit participate study , case affect clinical trial result ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>